-+ 0.00%
-+ 0.00%
-+ 0.00%

StoneX Downgrades Harvard Bioscience to Hold

Benzinga·11/11/2026 13:30:31
Listen to the news
StoneX analyst Bruce D. Jackson downgrades Harvard Bioscience (NASDAQ:HBIO) from Speculative Buy to Hold.